Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 5
2005 4
2006 2
2007 6
2008 8
2009 11
2010 7
2011 5
2012 7
2013 7
2014 8
2015 11
2016 9
2017 13
2018 11
2019 6
2020 9
2021 15
2022 24
2023 24
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Risk of diabetic retinopathy according to subtype of type 2 diabetes.
Pedersen FN, Stokholm L, Andersen N, Andresen J, Bek T, Hajari J, Heegaard S, Højlund K, Kawasaki R, Laugesen CS, Möller S, Schielke K, Nielsen JS, Stidsen JV, Thomsen RW, Thinggaard B, Grauslund J. Pedersen FN, et al. Among authors: hojlund k. Diabetes. 2024 Mar 18:db240016. doi: 10.2337/db24-0016. Online ahead of print. Diabetes. 2024. PMID: 38498373
Low-grade inflammation in persons with recently diagnosed type 2 diabetes: The role of abdominal adiposity and putative mediators.
Domazet SL, Olesen TB, Stidsen JV, Svensson CK, Nielsen JS, Thomsen RW, Jessen N, Vestergaard P, Andersen MK, Hansen T, Brøns C, Jensen VH, Vaag AA, Olsen MH, Højlund K. Domazet SL, et al. Among authors: hojlund k. Diabetes Obes Metab. 2024 Jun;26(6):2092-2101. doi: 10.1111/dom.15514. Epub 2024 Mar 11. Diabetes Obes Metab. 2024. PMID: 38465689
Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model.
Helmink MAG, Hageman SHJ, Eliasson B, Sattar N, Visseren FLJ, Dorresteijn JAN, Harris K, Peters SAE, Woodward M, Szentkúti P, Højlund K, Henriksen JE, Sørensen HT, Serné EH, van Sloten TT, Thomsen RW, Westerink J. Helmink MAG, et al. Among authors: hojlund k. Diabetes Obes Metab. 2024 Jun;26(6):2229-2238. doi: 10.1111/dom.15531. Epub 2024 Mar 8. Diabetes Obes Metab. 2024. PMID: 38456579
Empagliflozin to elderly and obese patients with increased risk of developing heart failure: Study protocol for the Empire Prevent trial program.
Andersen CF, Larsen JH, Jensen J, Omar M, Nouhravesh N, Kistorp C, Tuxen C, Gustafsson F, Knop FK, Forman JL, Davidovski FS, Jensen LT, Højlund K, Køber L, Antonsen L, Poulsen MK, Schou M, Møller JE. Andersen CF, et al. Among authors: hojlund k. Am Heart J. 2024 May;271:84-96. doi: 10.1016/j.ahj.2024.02.005. Epub 2024 Feb 15. Am Heart J. 2024. PMID: 38365073 Free article.
Diabetic retinopathy as an independent marker of cardiovascular disease in type 1 diabetes: Results from a nationwide longitudinal matched case-cohort study.
Mabala DS, Stokholm L, Andersen N, Andresen J, Bek T, Heegaard S, Hajari J, Højlund K, Kawasaki R, Laugesen CS, Möller S, Pedersen FN, Schielke KC, Thykjaer AS, Grauslund J. Mabala DS, et al. Among authors: hojlund k. Acta Ophthalmol. 2024 Feb 12. doi: 10.1111/aos.16653. Online ahead of print. Acta Ophthalmol. 2024. PMID: 38345204
Longitudinal bidirectional associations between diabetic retinopathy and diagnosed depression: Results from a Danish nationwide registry-based cohort study.
Pedersen FN, Stokholm L, Andersen N, Andresen J, Bek T, Hajari JN, Heegaard S, Højlund K, Kawasaki R, Möller S, Laugesen CS, Schielke KC, Thykjær AS, Peto T, Pouwer F, Grauslund J. Pedersen FN, et al. Among authors: hojlund k. J Diabetes Complications. 2023 Oct;37(10):108589. doi: 10.1016/j.jdiacomp.2023.108589. Epub 2023 Aug 24. J Diabetes Complications. 2023. PMID: 37657405 Free article.
A six-month low-carbohydrate diet high in fat does not adversely affect endothelial function or markers of low-grade inflammation in patients with type 2 diabetes: an open-label randomized controlled trial.
Gram-Kampmann EM, Olesen TB, Hansen CD, Hugger MB, Jensen JM, Handberg A, Beck-Nielsen H, Krag A, Olsen MH, Højlund K. Gram-Kampmann EM, et al. Among authors: hojlund k. Cardiovasc Diabetol. 2023 Aug 17;22(1):212. doi: 10.1186/s12933-023-01956-8. Cardiovasc Diabetol. 2023. PMID: 37592243 Free PMC article. Clinical Trial.
170 results